HLA Class-II?Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients. (2021)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2021.03.014
PubMed Identifier: 33798536
Publication URI: http://europepmc.org/abstract/MED/33798536
Type: Journal Article/Review
Volume: 141
Parent Publication: The Journal of investigative dermatology
Issue: 10
ISSN: 0022-202X